Ensign Peak Advisors Portfolio holdings
AUM
$58.4B
1-Year Return
23.83%
This Quarter Return
+13.33%
1 Year Return
+23.83%
3 Year Return
+106.64%
5 Year Return
+193.2%
10 Year Return
–
AUM
$54.8B
AUM Growth
+$4.24B
(+8.4%)
Cap. Flow
-$455M
Cap. Flow
% of AUM
-0.83%
Top 10 Holdings %
Top 10 Hldgs %
29.94%
Holding
1,776
New
37
Increased
449
Reduced
1,142
Closed
51
Top Buys
| 1 |
Eli Lilly
LLY
|
+$172M |
| 2 |
Uber
UBER
|
+$118M |
| 3 |
Blackstone Secured Lending
BXSL
|
+$103M |
| 4 |
PayPal
PYPL
|
+$82.8M |
| 5 |
Amazon
AMZN
|
+$82.5M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$182M |
| 2 |
Crown Castle
CCI
|
+$168M |
| 3 |
CME Group
CME
|
+$128M |
| 4 |
Gilead Sciences
GILD
|
+$113M |
| 5 |
Amgen
AMGN
|
+$111M |
Sector Composition
| 1 | Technology | 28.82% |
| 2 | Healthcare | 15.16% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 9.82% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Arbor Realty Trust
ABR
$2.28B
| $809K | ﹤0.01% |
61,069
-3,081
| -5% | -$40.8K |
|
1452
Bankunited
BKU
$2.88B
| $808K | ﹤0.01% |
28,873
-1,457
| -5% | -$40.8K |
|
|
JBGS
1453
JBG SMITH
JBGS
$1.42B
| $808K | ﹤0.01% |
50,369
-2,541
| -5% | -$40.8K |
|
1454
Xencor
XNCR
$593M
| $808K | ﹤0.01% |
36,527
-1,843
| -5% | -$40.8K |
|
1455
Chefs' Warehouse
CHEF
$2.63B
| $808K | ﹤0.01% |
21,458
-1,082
| -5% | -$40.7K |
|
1456
PTC Therapeutics
PTCT
$4.64B
| $807K | ﹤0.01% |
27,741
-1,399
| -5% | -$40.7K |
|
1457
Ovintiv
OVV
$10.7B
| $806K | ﹤0.01% |
+15,535
| New | +$806K |
|
1458
Bloom Energy
BE
$12.9B
| $805K | ﹤0.01% |
71,617
-3,613
| -5% | -$40.6K |
|
1459
MillerKnoll
MLKN
$1.41B
| $804K | ﹤0.01% |
32,480
-1,639
| -5% | -$40.6K |
|
1460
PJT Partners
PJT
$4.36B
| $804K | ﹤0.01% |
8,530
-430
| -5% | -$40.5K |
|
1461
Intellia Therapeutics
NTLA
$1.23B
| $802K | ﹤0.01% |
29,169
-1,471
| -5% | -$40.5K |
|
1462
Cushman & Wakefield
CWK
$3.71B
| $802K | ﹤0.01% |
76,663
-3,867
| -5% | -$40.4K |
|
1463
Brady Corp
BRC
$3.73B
| $802K | ﹤0.01% |
13,521
-682
| -5% | -$40.4K |
|
1464
Verint Systems
VRNT
$1.23B
| $800K | ﹤0.01% |
24,133
-1,217
| -5% | -$40.3K |
|
1465
Eastern Bankshares
EBC
$3.41B
| $800K | ﹤0.01% |
58,051
-2,929
| -5% | -$40.4K |
|
1466
Apogee Therapeutics
APGE
$2.29B
| $797K | ﹤0.01% |
+12,000
| New | +$797K |
|
1467
Werner Enterprises
WERN
$1.7B
| $797K | ﹤0.01% |
20,378
-1,028
| -5% | -$40.2K |
|
1468
Sonos
SONO
$1.82B
| $795K | ﹤0.01% |
41,697
-2,103
| -5% | -$40.1K |
|
1469
Stepan Co
SCL
$1.11B
| $793K | ﹤0.01% |
8,802
-444
| -5% | -$40K |
|
|
BBT
1470
Beacon Financial Corporation
BBT
$2.23B
| $790K | ﹤0.01% |
34,452
-1,738
| -5% | -$39.8K |
|
|
BWIN
1471
Baldwin Insurance Group
BWIN
$2.25B
| $787K | ﹤0.01% |
27,198
-1,372
| -5% | -$39.7K |
|
1472
Chesapeake Utilities
CPK
$2.93B
| $784K | ﹤0.01% |
7,302
-368
| -5% | -$39.5K |
|
1473
Protagonist Therapeutics
PTGX
$3.66B
| $782K | ﹤0.01% |
27,036
-1,364
| -5% | -$39.5K |
|
|
VIGL
1474
DELISTED
Vigil Neuroscience
VIGL
| $780K | ﹤0.01% |
228,674
| – | – |
|
1475
DNOW Inc
DNOW
$1.63B
| $779K | ﹤0.01% |
51,242
-2,585
| -5% | -$39.3K |
|